[Evaluation of newborns with brain disease using 123I-IMP SPECT]

Area of Science:

• Neurology
• Nuclear Medicine
• Pediatrics

Background:

• Cerebral disease in newborns requires accurate diagnostic tools.
• Cerebral blood flow assessment is crucial for diagnosing and managing neonatal neurological conditions.
• 123I-IMP SPECT is a functional imaging technique used to evaluate brain perfusion.

Purpose of the Study:

• To evaluate the utility of 123I-IMP SPECT in assessing cerebral disease in newborns.
• To characterize the findings of 123I-IMP SPECT in normal neonates and those with specific conditions.
• To explore the prognostic value of 123I-IMP SPECT in hypoxic ischemic encephalopathy (HIE).

Main Methods:

• Eleven newborns with suspected cerebral disease underwent 123I-IMP SPECT imaging.
• Analysis of tracer uptake patterns in different brain regions.
• Correlation of imaging findings with clinical diagnoses and prognosis.

Main Results:

• Normal neonates showed high uptake in the sensorimotor cortex, thalamus, midbrain-brainstem, and cerebellar vermis.
• Hypoxic ischemic encephalopathy (HIE) cases exhibited diffuse decreased uptake with no white matter redistribution, correlating with poor prognosis.
• One HIE patient with a persistent parasagittal defect also had a poor prognosis.
• Tuberous sclerosis cases showed high uptake in areas of increased density on CT scans.
• Neonatal 123I-IMP SPECT findings differ from adult patterns.

Conclusions:

• 123I-IMP SPECT demonstrates characteristic findings in newborns with cerebral disease.
• The tracer may possess prognostic value for clinical improvement in HIE.
• Further research is warranted to validate these findings and expand clinical applications.